LALPATHLAB•NSE
Need professional-grade analysis? Visit stockanalysis.com
₹1,402.10
-0.62%
End of day
Market Cap
$235.57B
P/E Ratio
44.60
Employees
4,980
Dividend Yield
0.90%
Price Chart
Risk-Adjusted Performance
Dr. Lal Path Labs Ltd. (LALPATHLAB) Price Performance
Dr. Lal Path Labs Ltd. (LALPATHLAB) trades on NSE in INR. The company is classified in the Healthcare sector under the Diagnostics & Research industry. The stock currently trades at INR1402.10, down 0.62% from the previous close.
Over the past year, LALPATHLAB has traded between a low of INR1308.20 and a high of INR25110.15. The stock has lost 12.3% over this period. It is currently 94.4% below its 52-week high.
Dr. Lal Path Labs Ltd. has a market capitalization of $235.57B, with a price-to-earnings ratio of 44.60 and a dividend yield of 0.90%.
About Dr. Lal Path Labs Ltd.
Dr. Lal PathLabs Limited operates laboratories for carrying out pathological investigations in India and internationally. The company provides pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It also offers phlebotomist training programs. The company was founded in 1949 and is based in Gurugram, India.
Company Info
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Exchange
- NSE
- Currency
- INR
- Country
- India
Financial Metrics
- Revenue (TTM)
- $26.63B
- EBITDA
- $7.15B
- Profit Margin
- 19.84%
- EPS (TTM)
- 31.63
- Book Value
- 143.09
Technical Indicators
- 52 Week High
- ₹25,110.15
- 52 Week Low
- ₹1,285.00
- 50 Day MA
- ₹1,379.80
- 200 Day MA
- ₹1,498.77
- Beta
- 0.10
Valuation
- Trailing P/E
- 44.60
- Forward P/E
- 50.25
- Price/Sales
- 8.85
- Price/Book
- 10.05
- Enterprise Value
- $228.22B